Recipharm acquires OnTarget Chemistry and extends its offering into preclinical development services. Recipharm has completed the acquisition of OnTarget Chemistry in Uppsala, Sweden. OnTarget Chemistry is a fast growing CRO company specialized in medicinal chemistry offering synthesis and analytical services which include rare and demanding specialties.  50% of the purchase price was paid in cash and the remaining 50% was paid through an issue in kind of 45.838 series B shares in Recipharm.

Hannes Snellman acted as legal advisor to Recipharm. The transaction team included: Claes Kjellberg, Caroline Wassdahl, Björn Kristiansson and Taymaz Afsari.